Clinical Trial Detail

Contact

Missing content? – Request curation!

Request curation for specific Genes, variants, or PubMed publications.

Have questions, comments or suggestions? - Let us know!

Email us at : ckbsupport@jax.org

NCT ID NCT01976741
Title Phase I Dose Escalation Pan-FGFR (Fibroblast Growth Factor Receptor) Inhibitor
Recruitment Completed
Gender both
Phase Phase I
Variant Requirements Yes
Sponsors Bayer
Indications

lung adenocarcinoma

lung non-small cell carcinoma

lung squamous cell carcinoma

urinary bladder cancer

head and neck cancer

Advanced Solid Tumor

Therapies

Rogaratinib

Age Groups: adult | senior
Covered Countries USA | FRA | ESP | DEU

Facility Status City State Zip Country Details
Chicago Illinois 60611-2908 United States Details
Chicago Illinois United States Details
Pittsburgh Pennsylvania 15232 United States Details
Besancon 25030 France Details
Creteil 94010 France Details
Dijon 21079 France Details
Lille Cedex 59020 France Details
Lyon Cedex 69008 France Details
Heidelberg Baden-Württemberg 69120 Germany Details
Tübingen Baden-Württemberg 72076 Germany Details
Weiden Bayern 92637 Germany Details
Würzburg Bayern 97080 Germany Details
Essen Nordrhein-Westfalen 45147 Germany Details
Köln Nordrhein-Westfalen 50937 Germany Details
Dresden Sachsen 01307 Germany Details
Hamburg 20246 Germany Details
Magdeburg 39120 Germany Details
Seoul 03080 Korea, Republic of Details
Seoul 03722 Korea, Republic of Details
Seoul 135-710 Korea, Republic of Details
Singapore 119228 Singapore Details
Singapore 169610 Singapore Details
Barcelona 08035 Spain Details
Madrid 28034 Spain Details
Madrid 28041 Spain Details
Valencia 46014 Spain Details
Chur Graubünden 7000 Switzerland Details
St. Gallen Sankt Gallen 9007 Switzerland Details
Genève 1205 Switzerland Details
*Shaded cells indicate that there was no data available from clincialtrials.gov for the field